1.1.1.43 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2774076&form=6&db=m [Role of disorders of pentosephosphate pathway of glucose oxidation in the pathogenesis of the arrest of fetal development in miscarriage] diagnostic usage,ongoing research,unassigned 2,1,0 1.1.1.43 Acidosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2783145&form=6&db=m Stimulation of rat-kidney hexose monophosphate shunt dehydrogenase activity by chronic metabolic acidosis. ongoing research,unassigned 4,0 1.1.1.43 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8809071&form=6&db=m Slow-binding inhibition of 6-phosphogluconate dehydrogenase by zinc ion. unassigned - 1.1.1.43 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26211962&form=6&db=m Escherichia coli 6-phosphogluconate dehydrogenase aids in tellurite resistance by reducing the toxicant in a NADPH-dependent manner. therapeutic application,unassigned 3,0 1.1.1.43 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3950618&form=6&db=m Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,1,0 1.1.1.43 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17570834&form=6&db=m Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 1.1.1.43 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1764909&form=6&db=m The relationship between red cell aging and enzyme activities in experimental animals. diagnostic usage,ongoing research,unassigned 1,3,0 1.1.1.43 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6883998&form=6&db=m Effect of anaemia on red cell metabolism in cattle. ongoing research,unassigned 4,0 1.1.1.43 Anemia, Hemolytic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4225373&form=6&db=m [Congenital nonspherocytic hemolytic anemia with incomplete deficiency of 6-phosphogluconate dehydrogenase] therapeutic application,unassigned 2,0 1.1.1.43 Anemia, Hemolytic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5449823&form=6&db=m [6 cases of inherited nonspherocytic hemolytic anemia associated with a deficit of 6-phosphogluconate dehydrogenase in the erythrocytes] diagnostic usage,unassigned 1,0 1.1.1.43 Anemia, Hemolytic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8948658&form=6&db=m Congenital 6-phosphogluconate dehydrogenase (6PGD) deficiency associated with chronic hemolytic anemia in a Spanish family. causal interaction,unassigned 4,0 1.1.1.43 Anemia, Hemolytic, Congenital http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4774551&form=6&db=m [Hereditary hemolytic anemia associated with insufficient activity of 6-phosphogluconate dehydrogenase of erythrocytes with hemoglobinuria following administration of drugs] causal interaction,therapeutic application,unassigned 2,1,0 1.1.1.43 Anemia, Hemolytic, Congenital Nonspherocytic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4225373&form=6&db=m [Congenital nonspherocytic hemolytic anemia with incomplete deficiency of 6-phosphogluconate dehydrogenase] therapeutic application,unassigned 2,0 1.1.1.43 Anemia, Iron-Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25097522&form=6&db=m The investigation of plasma glucose-6-phosphate dehydrogenase, 6-phoshogluconate dehydrogenase, glutathione reductase in premenauposal patients with iron deficiency anemia. diagnostic usage,unassigned 3,0 1.1.1.43 Arsenic Poisoning http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14421465&form=6&db=m [Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activity in arsenic poisoning and in hypoxemia caused by sodium nitrite.] unassigned - 1.1.1.43 Ascorbic Acid Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=196059&form=6&db=m Phagocytosis and leukocyte enzymes in ascorbic acid deficient guinea pigs. causal interaction,unassigned 1,0 1.1.1.43 Avitaminosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=394645&form=6&db=m [Limited-time feeding ("meal-feeding") and avitaminosis A : respiratory exchange and metabolic adaptation in rats] unassigned - 1.1.1.43 beta-Thalassemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5877942&form=6&db=m [Study of the enzymatic activities in the erythrocytes and platelets of subjects with Mediterranean anemia. V. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities of thalassemic platelets] diagnostic usage,ongoing research,unassigned 1,3,0 1.1.1.43 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3161533&form=6&db=m The effects of the administration of tamoxifen, ethynyloestradiol, and prednisolone on the activities of certain enzymes of carbohydrate metabolism in primary human breast carcinomas in vivo. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 1.1.1.43 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3797962&form=6&db=m The value of 6-phosphogluconate dehydrogenase (6-PGDH) activity as a marker of tumour cellularity and prognostic indicator in primary breast cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 1.1.1.43 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6294937&form=6&db=m Effects of opiates and naloxone on certain enzymes of carbohydrate metabolism in human breast carcinomas. ongoing research,unassigned 4,0 1.1.1.43 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29340974&form=6&db=m Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,4 1.1.1.43 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33498665&form=6&db=m Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism. causal interaction,ongoing research,therapeutic application,unassigned 2,4,4,0 1.1.1.43 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26479318&form=6&db=m 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,2,4 1.1.1.43 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32039535&form=6&db=m 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 1.1.1.43 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32801914&form=6&db=m Discovery of Ebselen as an Inhibitor of 6PGD for Suppressing Tumor Growth. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,4,4 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2064345&form=6&db=m A randomized clinical trial to investigate the usefulness of the addition of prednisolone to tamoxifen as adjuvants to mastectomy in primary breast cancer patients with a high risk of recurrence: a preliminary report. diagnostic usage,ongoing research,unassigned 4,1,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3161533&form=6&db=m The effects of the administration of tamoxifen, ethynyloestradiol, and prednisolone on the activities of certain enzymes of carbohydrate metabolism in primary human breast carcinomas in vivo. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4284722&form=6&db=m The early diagnosis of carcinoma of the female genital tract. I. 6-phosphogluconate dehydrogenase activity and carcinoma of the female genital tract. causal interaction,diagnostic usage,ongoing research,unassigned 1,1,1,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5218316&form=6&db=m Evaluation of 6-phosphogluconate dehydrogenase in carcinoma in situ of the cervix. diagnostic usage,unassigned 1,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5523809&form=6&db=m [Histoenzymatic studies of cervical carcinoma. II. Glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, TPN diaphorase and DPN diaphorase] therapeutic application,unassigned 1,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5558596&form=6&db=m Determination of 6-PGDH in the vaginal secretions of patients with carcinoma of the cervix. A new method of collection of vaginal secretions. diagnostic usage,unassigned 1,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5881531&form=6&db=m [Is a diagnosis of genital carcinomas by determination of the 6-phosphogluconate dehydrogenase activity of vaginal secretion possible?] diagnostic usage,unassigned 2,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5891592&form=6&db=m The early diagnosis of carcinoma of the female genital tract. II. Vaginal fluid 6-phosphogluconate dehydrogenase activity as a test for carcinoma of the cervix. causal interaction,diagnostic usage,unassigned 1,4,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6044933&form=6&db=m [Our experience with the glucose-6-phosphate and 6-phosphogluconate dehydrogenase tests in the diagnosis of gynecologic carcinoma] diagnostic usage,unassigned 4,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6189658&form=6&db=m Enzyme studies in human prostatic tissues. causal interaction,diagnostic usage,unassigned 1,1,0 1.1.1.43 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14211756&form=6&db=m USE OF 6-PHOSPHOGLUCONATE DEHYDROGENASE AS A SCREEN TEST FOR CERVICAL CARCINOMA IN NORMAL WOMEN. diagnostic usage,therapeutic application,unassigned 4,2,0 1.1.1.43 Carcinoma in Situ http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5218316&form=6&db=m Evaluation of 6-phosphogluconate dehydrogenase in carcinoma in situ of the cervix. diagnostic usage,unassigned 1,0 1.1.1.43 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=454718&form=6&db=m [Activities of dehydrogenases of the pentose phosphate pathway and transketolase in transplanted mouse hepatomas with different growth rates and in organs of tumor carriers] ongoing research,unassigned 3,0 1.1.1.43 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1381200&form=6&db=m Uridine and cytidine nucleotide synthesis in renal hypertrophy: biochemical differences in response to the growth stimulus of diabetes and unilateral nephrectomy. causal interaction,ongoing research,unassigned 4,1,0 1.1.1.43 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12502759&form=6&db=m Post-translational regulation of glucose-6-phosphate dehydrogenase activity in (pre)neoplastic lesions in rat liver. diagnostic usage,ongoing research,unassigned 3,3,0 1.1.1.43 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28739529&form=6&db=m Control of the NADPH supply for oxidative stress handling in cancer cells. ongoing research,unassigned 2,0 1.1.1.43 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32336239&form=6&db=m The positive feedback loop between Nrf2 and phosphogluconate dehydrogenase stimulates proliferation and clonogenicity of human hepatoma cells. ongoing research,unassigned 4,0 1.1.1.43 Cataract http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8360018&form=6&db=m Enzyme activities in human lens epithelium of age-related cataract. ongoing research,unassigned 3,0 1.1.1.43 Cervical Intraepithelial Neoplasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1637668&form=6&db=m Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. diagnostic usage,ongoing research,unassigned 2,3,0 1.1.1.43 Chagas Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14698432&form=6&db=m The 6-phosphogluconate dehydrogenase from Trypanosoma cruzi: the absence of two inter-subunit salt bridges as a reason for enzyme instability. causal interaction,therapeutic application,unassigned 3,4,0 1.1.1.43 Chemical and Drug Induced Liver Injury http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17180922&form=6&db=m [Catalytic properties of 6-phosphogluconate dehydrogenase from rat liver in normal state and during toxic hepatitis] ongoing research,therapeutic application,unassigned 4,1,0 1.1.1.43 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1441191&form=6&db=m Some glucose metabolic enzymes in various fractions of sarcocysts of Sarcocystis fusiformis of buffalo (Bubalus bubalis). causal interaction,diagnostic usage,unassigned 1,3,0 1.1.1.43 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24203202&form=6&db=m A full set of monosomic addition lines in Beta vulgaris from Beta webbiana: morphology and isozyme markers. diagnostic usage,unassigned 1,0 1.1.1.43 Dermatitis, Contact http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1027227&form=6&db=m [Enzymatic activity of the pentosephosphate pathway of carbohydrate conversion in the experimental therapy of dermatitis in rats] ongoing research,unassigned 2,0 1.1.1.43 Down Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4260604&form=6&db=m 6-phosphogluconate dehydrogenase (6-P-GD) in Down's syndrome. unassigned - 1.1.1.43 Duodenal Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=919374&form=6&db=m [Characteristics of the pentose phosphate pathway of carbohydrate metabolism in the gastric mucosa of persons with peptic ulcer] ongoing research,unassigned 2,0 1.1.1.43 Fatty Liver http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3772307&form=6&db=m Biochemical changes in liver and blood during liver fattening in rats. causal interaction,therapeutic application,unassigned 1,1,0 1.1.1.43 Gastrointestinal Stromal Tumors http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32719331&form=6&db=m HIF-1? regulates cellular metabolism, and Imatinib resistance by targeting phosphogluconate dehydrogenase in gastrointestinal stromal tumors. causal interaction,therapeutic application,unassigned 2,2,0 1.1.1.43 glucose-6-phosphate dehydrogenase (nadp+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1143145&form=6&db=m The detection of glucose-6-phosphate dehydrogenase deficiency in mediterraneans by comparative quantitative enzyme electrophoresis. diagnostic usage,unassigned 3,0 1.1.1.43 glucose-6-phosphate dehydrogenase (nadp+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5715190&form=6&db=m The Thai variant and the distribution of alleles of 6-phosphogluconate dehydrogenase and the distribution of glucose 6-phosphate dehydrogenase deficiency in Thailand. causal interaction,diagnostic usage,unassigned 3,3,0 1.1.1.43 glucose-6-phosphate dehydrogenase (nadp+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6150753&form=6&db=m Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis. causal interaction,therapeutic application,unassigned 3,1,0 1.1.1.43 Glucosephosphate Dehydrogenase Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1143145&form=6&db=m The detection of glucose-6-phosphate dehydrogenase deficiency in mediterraneans by comparative quantitative enzyme electrophoresis. diagnostic usage,unassigned 3,0 1.1.1.43 Glucosephosphate Dehydrogenase Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6150753&form=6&db=m Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis. causal interaction,therapeutic application,unassigned 3,1,0 1.1.1.43 glutathione-disulfide reductase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4144490&form=6&db=m Visual test for erythrocytic glucose-6-phosphate dehydrogenase, 6-phosphogluconic dehydrogenase, and glutathione reductase deficiencies. therapeutic application,unassigned 1,0 1.1.1.43 Hemoglobinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4774551&form=6&db=m [Hereditary hemolytic anemia associated with insufficient activity of 6-phosphogluconate dehydrogenase of erythrocytes with hemoglobinuria following administration of drugs] causal interaction,therapeutic application,unassigned 2,1,0 1.1.1.43 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8595093&form=6&db=m Effect of schistosomal infection and its treatment on some key enzymes of glucose metabolism in mice livers. causal interaction,unassigned 3,0 1.1.1.43 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18403138&form=6&db=m Cloning, expression and characterization of a cell wall surface protein, 6-phosphogluconate-dehydrogenase, of Streptococcus suis serotype 2. ongoing research,unassigned 3,0 1.1.1.43 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19253743&form=6&db=m [Glycolysis and pentose-phosphate pathway ratio in staphylococcus from the female genitalia in norm and dysbiosis] diagnostic usage,therapeutic application,unassigned 3,1,0 1.1.1.43 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21840023&form=6&db=m Cloning, expression and characterization of a cell wall surface protein, 6-phosphogluconate dehydrogenase, of Haemophilus parasuis. unassigned - 1.1.1.43 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24096100&form=6&db=m Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase. therapeutic application,unassigned 4,0 1.1.1.43 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25956945&form=6&db=m Effects of 5,8-dimethylthieno[2,3-b]quinoline-2-carboxylic acid on the antioxidative defense and lipid membranes in Plasmodium berghei-infected erythrocytes. diagnostic usage,ongoing research,unassigned 1,2,0 1.1.1.43 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33562490&form=6&db=m Blunted Reducing Power Generation in Erythrocytes Contributes to Oxidative Stress in Prepubertal Obese Children with Insulin Resistance. unassigned - 1.1.1.43 Iron Overload http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30506659&form=6&db=m In vitro and in vivo effects of iron on the expression and activity of glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and glutathione reductase in rat spleen. ongoing research,unassigned 3,0 1.1.1.43 Ketosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5005510&form=6&db=m [Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activity in animals with experimental ketosis] therapeutic application,unassigned 1,0 1.1.1.43 Laryngeal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12741142&form=6&db=m [Activity of the enzymatic antioxidant system depends on the clinical stage of laryngeal cancer ] diagnostic usage,ongoing research,unassigned 3,1,0 1.1.1.43 Leishmaniasis, Cutaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6780226&form=6&db=m [Leishmania infantum Nicolle, 1908, the agent of the autochthonous oriental sore. Apropos of the biochemical identification of 2 strains isolated in the eastern Pyrenees] diagnostic usage,unassigned 3,0 1.1.1.43 Leishmaniasis, Cutaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9574789&form=6&db=m Isoenzyme characterization of Leishmania isolated from human cases with localized cutaneous leishmaniasis from the State of Campeche, Yucatan Peninsula, Mexico. causal interaction,diagnostic usage,unassigned 1,1,0 1.1.1.43 Leprosy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=162080&form=6&db=m Genetic markers and leprosy in South African negroes: Part II. Erythrocyte enzyme polymorphisms. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 1.1.1.43 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=236846&form=6&db=m Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes. causal interaction,diagnostic usage,ongoing research,unassigned 1,1,1,0 1.1.1.43 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5249272&form=6&db=m 6-phosphogluconate dehydrogenase: hemizygous manifestation in a patient with leukemia. diagnostic usage,unassigned 2,0 1.1.1.43 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27270429&form=6&db=m Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin. causal interaction,ongoing research,therapeutic application,unassigned 1,1,4,0 1.1.1.43 Leukemia, Myeloid, Acute http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=236846&form=6&db=m Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes. causal interaction,diagnostic usage,ongoing research,unassigned 1,1,1,0 1.1.1.43 Leukemia, Myeloid, Acute http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28978059&form=6&db=m Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming. ongoing research,unassigned 3,0 1.1.1.43 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22677172&form=6&db=m Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. causal interaction,ongoing research,therapeutic application,unassigned 4,2,4,0 1.1.1.43 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24018234&form=6&db=m One-step purification of soluble recombinant human 6-phosphogluconate dehydrogenase from Escherichia coli. causal interaction,ongoing research,therapeutic application,unassigned 3,1,1,0 1.1.1.43 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28713273&form=6&db=m Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,1,4 1.1.1.43 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31504235&form=6&db=m YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation. ongoing research,unassigned 1,0 1.1.1.43 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32177673&form=6&db=m Investigation of the combined action of cisplatin and 6-phosphogluconate dehydrogenase inhibitor on pancreatic and lung cancer cell lines. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,3,0 1.1.1.43 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=351525&form=6&db=m Studies on enzyme variation in the murine malaria parasites Plasmodium berghei, P. yoelii, P. vinckei and P. chabaudi by starch gel electrophoresis. ongoing research,unassigned 2,0 1.1.1.43 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2936261&form=6&db=m Resistance to falciparum malaria among adults in central Sudan. causal interaction,therapeutic application,unassigned 2,1,0 1.1.1.43 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4201713&form=6&db=m An electron cytochemical study of 6-phosphogluconate dehydrogenase activity in infected erythrocytes during malaria. ongoing research,unassigned 4,0 1.1.1.43 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30098336&form=6&db=m Characterization of Plasmodium falciparum 6-Phosphogluconate Dehydrogenase as an Antimalarial Drug Target. unassigned - 1.1.1.43 Muscular Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3532684&form=6&db=m Activities of some antioxidative and hexose monophosphate shunt enzymes of skeletal muscle in neuromuscular diseases. causal interaction,diagnostic usage,unassigned 2,4,0 1.1.1.43 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=45625&form=6&db=m [The activity of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in skeletal muscle tissues of patients with muscular diseases] diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 1.1.1.43 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6480400&form=6&db=m The inhibitory effect of actinomycin D and cycloheximide on the increase in activity of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in experimentally induced diseased skeletal muscles. causal interaction,unassigned 3,0 1.1.1.43 Muscular Dystrophy, Duchenne http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7470100&form=6&db=m Changes in some cytoplasmic enzymes from red cells fractionated into age groups by centrifugation in Ficoll/Triosil gradients. Comparison of normal humans and patients with Duchenne muscular dystrophy. diagnostic usage,ongoing research,unassigned 3,4,0 1.1.1.43 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3430187&form=6&db=m Additional biochemical criteria in the differential diagnosis of myositis. causal interaction,diagnostic usage,unassigned 2,4,0 1.1.1.43 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8226108&form=6&db=m Experimentally induced colon cancer metastases in rat liver increase the proliferation rate and capacity for purine catabolism in liver cells. diagnostic usage,ongoing research,unassigned 1,1,0 1.1.1.43 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29849117&form=6&db=m Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases. ongoing research,therapeutic application,unassigned 1,1,0 1.1.1.43 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32039535&form=6&db=m 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=123168&form=6&db=m Influence of insulin on estrogen-induced responses in the r3230ac mammary carcinoma. unassigned - 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=454718&form=6&db=m [Activities of dehydrogenases of the pentose phosphate pathway and transketolase in transplanted mouse hepatomas with different growth rates and in organs of tumor carriers] ongoing research,unassigned 3,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=645360&form=6&db=m Activities of enzymes of the hexose monophosphate pathway in nervous system tumors induced by ethylnitrosourea. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=741521&form=6&db=m 6-phosphogluconate dehydrogenase, glucose-6-phosphate dehydrogenase, glucose-6-phosphate isomerase, and hexokinase activity ratios in some human tumor cytosols. ongoing research,unassigned 2,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1381200&form=6&db=m Uridine and cytidine nucleotide synthesis in renal hypertrophy: biochemical differences in response to the growth stimulus of diabetes and unilateral nephrectomy. causal interaction,ongoing research,unassigned 4,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1637668&form=6&db=m Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. diagnostic usage,ongoing research,unassigned 2,3,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2324341&form=6&db=m Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in normal canine mammary gland and in mammary tumours and their correlation with oestrogen receptors. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,2,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2894933&form=6&db=m Biochemical tissue markers of human colorectal carcinoma. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,3,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3797962&form=6&db=m The value of 6-phosphogluconate dehydrogenase (6-PGDH) activity as a marker of tumour cellularity and prognostic indicator in primary breast cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5232019&form=6&db=m Trial of a simplified vaginal fluid 6-phosphogluconic dehydrogenase assay method in screening for cancer. diagnostic usage,unassigned 4,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5429014&form=6&db=m A modified assay for 6-phosphogluconate dehydrogenase in samples of vaginal fluid from women with and without gynecologic cancer. diagnostic usage,unassigned 3,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5847905&form=6&db=m Vaginal fluid 6-phosphogluconic dehydrogenase activity in relation to uterine malignancy. diagnostic usage,unassigned 3,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6027709&form=6&db=m Detection of preinvasive and early invasive cancer by 6-phosphogluconate dehydrogenase determinations. causal interaction,diagnostic usage,unassigned 3,2,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6234985&form=6&db=m Inhibition of 6-phosphogluconate dehydrogenase by glucose 1,6-diphosphate in human normal and malignant colon extracts. causal interaction,diagnostic usage,ongoing research,unassigned 1,1,2,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6746113&form=6&db=m Enhanced susceptibility to a chemical carcinogen in rats carrying MHC-linked genes influencing development (GRC). causal interaction,unassigned 3,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7347823&form=6&db=m [Hexokinase activity of erythrocytes in cancer patients] diagnostic usage,ongoing research,unassigned 1,3,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8955144&form=6&db=m Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. ongoing research,unassigned 2,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13870993&form=6&db=m A new enzyme test for gynaecological cancer. 6-Phosphogluconate dehydrogenase activity in vaginal fluid. diagnostic usage,unassigned 3,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14154689&form=6&db=m A NEW TEST FOR THE DIAGNOSIS OF GYNAECOLOGICAL CANCER, 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID. diagnostic usage,therapeutic application,unassigned 4,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14288104&form=6&db=m 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID: LIMITATIONS AS A SCREENING TEST FOR GENITAL CANCER. diagnostic usage,therapeutic application,unassigned 4,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17570834&form=6&db=m Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18665625&form=6&db=m Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. unassigned - 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22677172&form=6&db=m Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. causal interaction,ongoing research,therapeutic application,unassigned 4,2,4,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23137315&form=6&db=m Potential antitumour and pro-oxidative effects of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate (QNACR). causal interaction,ongoing research,therapeutic application,unassigned 1,1,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23973484&form=6&db=m 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met. diagnostic usage,ongoing research,therapeutic application,unassigned 1,4,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24096100&form=6&db=m Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase. therapeutic application,unassigned 4,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25042803&form=6&db=m Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. causal interaction,ongoing research,therapeutic application,unassigned 4,3,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26479318&form=6&db=m 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,2,4 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28739529&form=6&db=m Control of the NADPH supply for oxidative stress handling in cancer cells. ongoing research,unassigned 2,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29340974&form=6&db=m Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,4 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29682102&form=6&db=m Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,4,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30824700&form=6&db=m Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31504235&form=6&db=m YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation. ongoing research,unassigned 1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31862471&form=6&db=m Mitochondrial glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase abrogate p53 induced apoptosis in a yeast model: Possible implications for apoptosis resistance in cancer cells. ongoing research,therapeutic application,unassigned 3,1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32039535&form=6&db=m 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32719331&form=6&db=m HIF-1? regulates cellular metabolism, and Imatinib resistance by targeting phosphogluconate dehydrogenase in gastrointestinal stromal tumors. causal interaction,therapeutic application,unassigned 2,2,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32801914&form=6&db=m Discovery of Ebselen as an Inhibitor of 6PGD for Suppressing Tumor Growth. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,4,4 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32829780&form=6&db=m 6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming. causal interaction,unassigned 4,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32880800&form=6&db=m Calcium Fructoborate Prevents Skin Cancer Development in Balb-c Mice: Next Part, Reverse Inflammation, and Metabolic Alteration. causal interaction,therapeutic application,unassigned 2,4,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33817181&form=6&db=m 1-Hydroxy-8-methoxy-anthraquinon Reverses Cisplatin Resistance by Inhibiting 6PGD in Cancer Cells. therapeutic application,unassigned 1,0 1.1.1.43 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34434214&form=6&db=m Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis. diagnostic usage,ongoing research,unassigned 1,1,0 1.1.1.43 Neurilemmoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3026558&form=6&db=m Characterization of rat schwannoma-Schwann cell hybrids. ongoing research,unassigned 3,0 1.1.1.43 Neuromuscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2748466&form=6&db=m Elevated activity of several antioxidant enzymes in neuromuscular diseases. A histochemical and biochemical study. ongoing research,unassigned 4,0 1.1.1.43 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22528625&form=6&db=m Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors. causal interaction,unassigned 1,0 1.1.1.43 Osteolysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29352728&form=6&db=m Differential proteomic analysis of synovial fluid from hip arthroplasty patients with a pseudotumor vs. Periprosthetic osteolysis?. causal interaction,therapeutic application,unassigned 2,1,0 1.1.1.43 Pancreatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32792504&form=6&db=m Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis. diagnostic usage,ongoing research,unassigned 3,1,0 1.1.1.43 phosphogluconate 2-dehydrogenase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4696191&form=6&db=m Erythrocytic glutathione reductase, glucose-6-phosphate dehydrogenase, and 6-phosphogluconic dehydrogenase deficiencies in populations of the United States, South Vietnam, Iran, and Ethiopia. unassigned - 1.1.1.43 phosphogluconate 2-dehydrogenase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11233775&form=6&db=m 6-Phosphogluconate dehydrogenase deficiency in an Italian family. causal interaction,diagnostic usage,unassigned 4,2,0 1.1.1.43 phosphogluconate 2-dehydrogenase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14250427&form=6&db=m A NEW INHERITED ENZYMATIC DEFICIENCY OF HUMAN ERYTHROCYTES: 6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY. causal interaction,unassigned 4,0 1.1.1.43 Primary Myelofibrosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1059470&form=6&db=m Blood leucocyte enzymes. II. Activities at 8-9 a.m. in cells of normal subjects, chronic lymphatic leukaemia and chronic myeloid leukaemia patients. diagnostic usage,unassigned 1,0 1.1.1.43 Psoriasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5124757&form=6&db=m [Evaluation of the activities of several erythrocyte enzymes (G6PDH, 6PGDH, PHI, aldolase and LDH) in psoriasis] unassigned - 1.1.1.43 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3823105&form=6&db=m Dietary induction of hepatic glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and malic enzyme in lean and obese female Zucker rats. ongoing research,unassigned 2,0 1.1.1.43 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7045591&form=6&db=m Pentose phosphate pathway mutants of yeast. therapeutic application,unassigned 1,0 1.1.1.43 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12498092&form=6&db=m [Intensity of pentose phosphate metabolism of carbohydrates in various brain areas in normal and starved animals] unassigned - 1.1.1.43 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19040112&form=6&db=m Expression of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase isoform genes in suspension-cultured Arabidopsis thaliana cells. unassigned - 1.1.1.43 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29379012&form=6&db=m Antimicrobial activity of apple cider vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; downregulating cytokine and microbial protein expression. therapeutic application,unassigned 1,0 1.1.1.43 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34484268&form=6&db=m Gm6PGDH1, a Cytosolic 6-Phosphogluconate Dehydrogenase, Enhanced Tolerance to Phosphate Starvation by Improving Root System Development and Modifying the Antioxidant System in Soybean. ongoing research,unassigned 3,0 1.1.1.43 Stomach Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=919374&form=6&db=m [Characteristics of the pentose phosphate pathway of carbohydrate metabolism in the gastric mucosa of persons with peptic ulcer] ongoing research,unassigned 2,0 1.1.1.43 Teratoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6961419&form=6&db=m Diverse origins of multiple ovarian teratomas in a single individual. diagnostic usage,unassigned 1,0 1.1.1.43 Thyroid Carcinoma, Anaplastic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29534964&form=6&db=m Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming. therapeutic application,unassigned 1,0 1.1.1.43 Trypanosomiasis, African http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12818683&form=6&db=m Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis. causal interaction,therapeutic application,unassigned 2,4,0 1.1.1.43 Trypanosomiasis, African http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14698432&form=6&db=m The 6-phosphogluconate dehydrogenase from Trypanosoma cruzi: the absence of two inter-subunit salt bridges as a reason for enzyme instability. causal interaction,therapeutic application,unassigned 3,4,0 1.1.1.43 Trypanosomiasis, African http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17615587&form=6&db=m Synthesis and Biological Evaluation of Phosphate Prodrugs of 4-Phospho-D -erythronohydroxamic Acid, an Inhibitor of 6-Phosphogluconate Dehydrogenase. therapeutic application,unassigned 2,0 1.1.1.43 Trypanosomiasis, African http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18021252&form=6&db=m Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase. causal interaction,therapeutic application,unassigned 4,4,0 1.1.1.43 Trypanosomiasis, African http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20598892&form=6&db=m Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase. therapeutic application,unassigned 3,0 1.1.1.43 Trypanosomiasis, African http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20666371&form=6&db=m Aryl phosphoramidates of 5-phospho erythronohydroxamic acid, a new class of potent trypanocidal compounds. therapeutic application,unassigned 4,0 1.1.1.43 Trypanosomiasis, African http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24096100&form=6&db=m Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase. therapeutic application,unassigned 4,0 1.1.1.43 Tuberous Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=166911&form=6&db=m Serum and tissue proteins in tuberous sclerosis. I. Serum and red-cell polymorphic systems. unassigned - 1.1.1.43 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14341115&form=6&db=m 6-PHOSPHOGLUCONATE DEHYDROGENASE ESTIMATION IN VAGINAL FLUID IN THE DIAGNOSIS OF CERVICAL CANCER. diagnostic usage,unassigned 4,0 1.1.1.43 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30182212&form=6&db=m Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,3,4 1.1.1.43 Uterine Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=508567&form=6&db=m Isoenzymes of hexokinase, 6-phosphogluconate dehydrogenase, phosphoglucomutase and lactate dehydrogenase in uterine cancer. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,2,0 1.1.1.43 Uterine Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5519624&form=6&db=m The alleged usefulness of 6-phosphogluconate dehydrogenase determinations in screening for uterine cancer. causal interaction,diagnostic usage,unassigned 1,3,0 1.1.1.43 Uterine Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14308735&form=6&db=m 6-PHOSPHOGLUCONATE DEHYDROGENASE IN UTERINE CANCER DETECTION. diagnostic usage,unassigned 1,0 1.1.1.43 Vitiligo http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6950922&form=6&db=m Distribution of serum proteins, red cell enzymes and haemoglobins in vitiligo. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,4,0 1.1.1.43 Yersinia pseudotuberculosis Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16561972&form=6&db=m GLUCOSE-6-PHOSPHATE DEHYDROGENASE AND 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITIES OF PASTEURELLA PESTIS AND PASTEURELLA PSEUDOTUBERCULOSIS. unassigned -